EMA Authorised: MenQuadfi (Neisseria meningitidis group C polysaccharide conjugated to tetanus toxoid;Neisseria meningitidis group A polysaccharide conjugated to tetanus toxoid;Neisseria meningitidis group Y polysaccharide conjugated to tetanus toxoid;Neisseria meningitidis group W-135 polysaccharide conjugated to tetanus toxoid) — Sanofi Winthrop Industrie

View source ↗

Summary

EMA has authorised MenQuadfi, a meningococcal vaccine combination covering groups A, C, W-135, and Y (tetanus toxoid-conjugated), for meningitis/meningococcal d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis
• Meningococcal Disease

Drugs mentioned

• MenQuadfi (Meningococcal quadrivalent conjugate vaccine)

Snippet

Status: Authorised. Therapeutic area: Meningitis, Meningococcal. MAH: Sanofi Winthrop Industrie. Decision date: 24/07/2026